Improving your health
At Novaphar, we innovate in the molecule to market lifecycle through a tailor-made process that provides a fast and competitive drug development, bridging the gap from innovation to patients
We are committed
with modern medicine to provide patients
better quality
of life
Collaboration is key to developing breakthrough therapies and bringing accessible novel treatments to patients, with a special focus on reducing the side effects many of the conventional pharmaceuticals often produce.
Our collaborative platform generates a unique scenario to properly allocate the enormous growth of the scientific research, coupled with rapid technological progress, allowing us to identify successful candidates and conduct research at a scale that would have been almost unimaginable a generation or two ago.
We are creating a new paradigm shift on how clinical trials are being conducted, making them less expensive, faster and more effective. The pandemic acts as a catalyst, allowing us to improve our performance in rapid identification of strong molecular candidates, AI, remote monitoring through innovative games platforms, use of wearables as data collectors, machine learning for electronic health records processing, to a live health record repository of 120+ million patients containing demographic and high-level epidemiological data.
